| Analysis | Metabolite Name | Measured Value | Units | Treatment |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | N-carbamoyl-L-aspartate | 1381.454 | Peak area (top) | ML162 |
| Reversed phase NEGATIVE ION MODE | N-carbamoyl-L-aspartate | 1570.204 | Peak area (top) | ML162 |
| Reversed phase NEGATIVE ION MODE | N-carbamoyl-L-aspartate | 1702.688 | Peak area (top) | ML162 |
| Reversed phase NEGATIVE ION MODE | N-carbamoyl-L-aspartate | 2948.04 | Peak area (top) | RSL3 |
| Reversed phase NEGATIVE ION MODE | N-carbamoyl-L-aspartate | 3505.445 | Peak area (top) | RSL3 |
| Reversed phase NEGATIVE ION MODE | N-carbamoyl-L-aspartate | 3973.615 | Peak area (top) | RSL3 |
| Reversed phase NEGATIVE ION MODE | N-carbamoyl-L-aspartate | 18512.93 | Peak area (top) | ML210 |
| Reversed phase NEGATIVE ION MODE | N-carbamoyl-L-aspartate | 25271.12 | Peak area (top) | ML210 |
| Reversed phase NEGATIVE ION MODE | N-carbamoyl-L-aspartate | 25377.45 | Peak area (top) | ML210 |
| Reversed phase NEGATIVE ION MODE | N-carbamoyl-L-aspartate | 52390.68 | Peak area (top) | DMSO |
| Reversed phase NEGATIVE ION MODE | N-carbamoyl-L-aspartate | 71836.77 | Peak area (top) | DMSO |
| Reversed phase NEGATIVE ION MODE | N-carbamoyl-L-aspartate | 85629.95 | Peak area (top) | DMSO |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|